#Ambify for windows professional#

But 26 percent of the Abilify group experienced a movement disorder called akathisia. It reported that in one of the trials, the combination successfully treated depression in 25 percent of patients compared with 15 percent who had been given a placebo. Consumer Reports found aripiprazole is “just as likely to induce a bad side effect as it is to help rid depression.” Steven Woloshin, a professor at Dartmouth Medical School, told Consumer Reports in 2010 that the trials failed to shed any light on the long-term effects of the combination treatment. The FDA approval was based on studies that lasted just six weeks.ĭr. About Įxperts Question Benefits of Combination TreatmentĬritics say the initial studies that won FDA approval for the combination treatment were too short or had too few participants.

#Ambify for windows professional#

Our writers are members of professional associations, including American Medical Writers Association, American Bar Association, The Alliance of Professional Health Advocates and International Society for Medical Publication Professionals. The information on has been medically and legally reviewed by more than 30 expert contributors, including doctors, pharmacists, lawyers, patient advocates and other health care professionals. This means the high-quality information we provide comes from credible sources, such as peer-reviewed medical journals and expert interviews. is HONCode (Health On the Net Foundation) certified. Our team includes experienced medical writers, award-winning journalists, researchers and certified medical and legal experts. We’ve also connected thousands of people injured by drugs and medical devices with top-ranked national law firms to take action against negligent corporations.

has provided reliable, trusted information about medications, medical devices and general health since 2008.